CS51492A3 - 2-substituted quinolines, process of their preparation and their use inmedicaments - Google Patents

2-substituted quinolines, process of their preparation and their use inmedicaments

Info

Publication number
CS51492A3
CS51492A3 CS92514A CS51492A CS51492A3 CS 51492 A3 CS51492 A3 CS 51492A3 CS 92514 A CS92514 A CS 92514A CS 51492 A CS51492 A CS 51492A CS 51492 A3 CS51492 A3 CS 51492A3
Authority
CS
Czechoslovakia
Prior art keywords
substituted
substituted quinolines
inmedicaments
preparation
quinolines
Prior art date
Application number
CS92514A
Other languages
English (en)
Inventor
Siegfried Dr Raddatz
Klaus-Helmut Dr Mohrs
Michael Dr Matzke
Romanis Fruchtmann
Armin Dr Hatzelmann
Christian Dr Kohlsdorfer
Reiner Prof Muller-Peddinghaus
Pia Dr Theisen-Popp
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of CS51492A3 publication Critical patent/CS51492A3/cs
Publication of CZ282723B6 publication Critical patent/CZ282723B6/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Electrically Operated Instructional Devices (AREA)
  • Earth Drilling (AREA)
CS92514A 1991-02-22 1992-02-21 2-Substituované chinoliny, způsob jejich přípravy a jejich použití v léčivech CZ282723B6 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4105551A DE4105551A1 (de) 1991-02-22 1991-02-22 2-substituierte chinoline, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln

Publications (2)

Publication Number Publication Date
CS51492A3 true CS51492A3 (en) 1992-12-16
CZ282723B6 CZ282723B6 (cs) 1997-09-17

Family

ID=6425643

Country Status (20)

Country Link
EP (1) EP0499926B1 (cs)
JP (1) JPH0592957A (cs)
KR (1) KR920016424A (cs)
AT (1) ATE142623T1 (cs)
AU (1) AU641585B2 (cs)
CZ (1) CZ282723B6 (cs)
DE (2) DE4105551A1 (cs)
DK (1) DK0499926T3 (cs)
ES (1) ES2091958T3 (cs)
FI (1) FI920732L (cs)
GR (1) GR3021014T3 (cs)
HU (1) HUT67037A (cs)
IE (1) IE75728B1 (cs)
IL (1) IL101009A (cs)
MY (1) MY108459A (cs)
NZ (1) NZ241654A (cs)
PL (2) PL170726B1 (cs)
RU (1) RU2077532C1 (cs)
TW (1) TW200463B (cs)
ZA (1) ZA921268B (cs)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304563A (en) * 1991-02-22 1994-04-19 Bayer Aktiengesellschaft 2-substituted quinolines, and their use in medicaments
DE4226649A1 (de) * 1992-08-12 1994-02-17 Bayer Ag Neue isobutylsubstituierte Methansulfonyl-chinolylmethoxyphenyl-cycloalkylessigsäureaminole
DE4112533A1 (de) * 1991-04-17 1992-10-22 Bayer Ag Verfahren zur herstellung von enantiomerenreinen substituierten (chinolin-2-yl-methoxy)phenyl-essigsaeuren
US5391555A (en) * 1991-11-12 1995-02-21 Miles Inc. Methods for treating inflammatory bowel disease with leukotriene synthesis inhibitors
TW232013B (cs) * 1992-04-24 1994-10-11 Takeda Pharm Industry Co Ltd
DE4219765A1 (de) * 1992-06-17 1993-12-23 Bayer Ag Substituierte (Benzothiazolyl- und Chinoxalyl-methoxy)phenylessigsäurederivate
DE4301900A1 (de) * 1993-01-25 1994-07-28 Bayer Ag 2-Oxochinolin-1-yl-methylphenylessigsäurederivate
ES2061406B1 (es) * 1993-05-07 1995-06-01 Uriach & Cia Sa J Nuevos derivados de la 2-(quinolina) con actividad farmacologica.
IL109431A (en) * 1993-05-14 2001-01-11 Warner Lambert Co Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds
US5491172A (en) * 1993-05-14 1996-02-13 Warner-Lambert Company N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
DE69422450T2 (de) * 1993-06-29 2000-06-08 Takeda Chemical Industries, Ltd. Chinoline oder Chinazolin-Derivate und deren Verwendung zur Herstellung eines Medikaments für die Behandlung von Osteoporose
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
DE4443891A1 (de) 1994-12-09 1996-06-13 Bayer Ag Heterocyclisch substituierte Oxy-phenyl-(phenyl)glycinolamide
EP1077957B1 (en) * 1998-05-11 2004-08-04 Takeda Chemical Industries, Ltd. Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity
GB9818641D0 (en) * 1998-08-26 1998-10-21 Rh Ne Poulenc Rorer Limited Chemical compounds
EP1177187B1 (en) * 1999-04-28 2007-07-25 Sanofi-Aventis Deutschland GmbH Di-aryl acid derivatives as ppar receptor ligands
RU2177317C1 (ru) * 2000-10-24 2001-12-27 Московский научно-исследовательский институт медицинской экологии (МНИИМЭ) Производные хинолина для коррекции системы гемостаза, фармацевтическая композиция, средство для коррекции гемостаза
TWI309644B (cs) * 2001-02-14 2009-05-11 Nissan Chemical Ind Ltd
US6867320B2 (en) 2002-02-21 2005-03-15 Asahi Kasei Pharma Corporation Substituted phenylalkanoic acid derivatives and use thereof
EP2284157A1 (en) 2003-12-12 2011-02-16 Wyeth Quinolines useful in treating cardiovascular disease
BRPI0518222A (pt) * 2004-10-19 2008-11-04 Hoffmann La Roche composto, processo para a sua manufatura, composições farmacêuticas que os compreendem, método para o tratamento e/ou prevenção de enfermidades que estão associadas com a modulação de receptores de h3 e utilização dos mesmos
PT2125786E (pt) * 2006-12-21 2011-04-21 Pfizer Prod Inc Sal succinato de 2-((4-(1-metil-4-(piridin-4-il)-1hpirazol- 3-il)fenoxi)metil)quinolina

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3814504A1 (de) * 1988-04-29 1989-11-09 Bayer Ag (alpha)-substituierte 4-(chinolin-2-yl-methoxy)phenylessigsaeuren und -ester, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3900261A1 (de) * 1988-05-31 1989-12-07 Bayer Ag Substituierte 4-(chinolin-2-yl-methoxy) phenyl-essigsaeure-derivate
DE3908298A1 (de) * 1989-03-14 1990-09-20 Bayer Ag Substituierte (chinolin-2-yl-methoxy)phenyl-n,n'-sulfonylharnstoffe, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3916663A1 (de) * 1989-05-23 1990-11-29 Bayer Ag Substituierte (chinolin-2-yl-methoxy)phenyl-acyl-sulfonamide und -cyanamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3927930A1 (de) * 1989-08-24 1991-02-28 Bayer Ag Cyclisch substituierte (chinolin-2-yl-methoxy)phenyl-essig-saeure-derivate
DE3927931A1 (de) * 1989-08-24 1991-02-28 Bayer Ag Disubstituierte (chinolin-2-yl-methoxy)phenylessigsaeure-derivate

Also Published As

Publication number Publication date
DE59207074D1 (de) 1996-10-17
DK0499926T3 (cs) 1997-02-10
FI920732A7 (fi) 1992-08-23
CZ282723B6 (cs) 1997-09-17
AU1054292A (en) 1992-08-27
RU2077532C1 (ru) 1997-04-20
TW200463B (cs) 1993-02-21
ATE142623T1 (de) 1996-09-15
MY108459A (en) 1996-09-30
JPH0592957A (ja) 1993-04-16
ZA921268B (en) 1992-11-25
FI920732L (fi) 1992-08-23
KR920016424A (ko) 1992-09-24
FI920732A0 (fi) 1992-02-20
PL171026B1 (pl) 1997-02-28
ES2091958T3 (es) 1996-11-16
HUT67037A (en) 1995-01-30
PL293534A1 (en) 1992-10-05
IL101009A0 (en) 1992-11-15
IE75728B1 (en) 1997-09-24
PL170726B1 (pl) 1997-01-31
IE920557A1 (en) 1992-08-26
GR3021014T3 (en) 1996-12-31
EP0499926A1 (de) 1992-08-26
NZ241654A (en) 1994-11-25
AU641585B2 (en) 1993-09-23
HU9200582D0 (en) 1992-05-28
DE4105551A1 (de) 1992-08-27
IL101009A (en) 1996-08-04
EP0499926B1 (de) 1996-09-11

Similar Documents

Publication Publication Date Title
CS51492A3 (en) 2-substituted quinolines, process of their preparation and their use inmedicaments
DK543787A (da) Naphthyridin-, quinolin- og benzoxazincarboxylsyreforbindelser med antibakteriel aktivitet
JPS5547658A (en) Substituted quinolinecarboxylic acid derivative
EP0302525A3 (en) Quinolones as antibacterial agents
AU533141B2 (en) Quinoline carboxylic acid derivatives
KR950011747B1 (en) Quinoline carboxylic acid perivatives
DK0612731T3 (da) Nye quinolon- og naphthyridoncarboxylsyrederivater
AU589415B2 (en) Improved process for quinoline-3-carboxylic acid antibacterial agents
JPS57145862A (en) Quinolinecarboxylic acid derivative
KR0148213B1 (en) Phenyla lkan(en)oic acid and pharmaceutical composition comprising the same
JPS57109754A (en) N-benzoyl-omega-anilinoalkane carboxylic acid compound
AU638437B2 (en) Substituted azetidinylpyridonecarboxylic acid derivatives, their preparation and their application as medicinal products
EP0207497A3 (en) Quinolonecarboxylic acid derivative and process for its preparation
GR3020230T3 (en) Acylsulphonamido and sulphonamidopyridine-2-carboxylic acid esters, pyridine-n-oxides thereof, a process for their preparation and their use as medicaments
ES483463A1 (es) Procedimiento de preparacion de los esteres del 1-metil-4- piperidinol
JPS5770889A (en) 1-ethyl-1,8-naphthyridine derivative and salt thereof
IE44610L (en) Piperidine derivatives.
IE42992L (en) PYRIMIDO [1,2-a] QUINOLINE DERIVATIVES
ES481296A1 (es) Un procedimiento para la preparacion de esteres de deriva- dos del acido aminolo-piran-4-ona-2-carboxilico.
ES2051225A1 (es) Procedimiento de preparacion del acido 1-etil-6-fluoro-7-(pirrol-1-il) -1,4-dihidro-4-oxo-3-quinoleincarboxilico.
JPS55100365A (en) Quinoline derivative and its preparation
IE811069L (en) Esters of substituted benzoic acid
GB1453427A (en) 4-oxo-1,2,3,4-tetrahydropyrido-2,3-d-pyrimidines